Literature DB >> 24646728

Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population.

Sujatha Suthandiram1, Gin Gin Gan2, Shamsul Mohd Zain1, Batoul Sadat Haerian1, Ping Chong Bee2, Lay Hoong Lian3, Kian Meng Chang4, Tee Chuan Ong4, Zahurin Mohamed1.   

Abstract

An imbalance in folate metabolism can adversely affect DNA synthesis and methylation systems which can lead to susceptibility to non-Hodgkin lymphoma (NHL). Whether single nucleotide polymorphisms (SNPs) and their haplotypes in the methylenetetrahydrofolate reductase (MTHFR) are associated with NHL, remain inconclusive. We investigated the association between MTHFR C677T and A1298C SNPs and NHL risk in a population which is made up of Malay, Chinese and Indian ethnic subgroups. A total of 372 NHL patients and 722 controls were genotyped using the Sequenom MassARRAY platform. Our results of the pooled subjects failed to demonstrate significant association between the MTHFR C677T and A1298C SNPs with NHL and its subtypes. The results were in agreement with the previous meta-analyses. In the Indian ethnic subgroup however, single locus analysis of MTHFR A1298C appears to confer risk to NHL (Odds ratio (OR) 1.91, 95% confidence interval (95% CI) 1.22-3.00, P=0.006). The risk is almost doubled in homozygous carrier of MTHFR 1298CC (OR 4.03, 95% CI 1.56-10.43, P=0.004). Haplotype analysis revealed higher frequency of CC in the Indian NHL patients compared with controls (OR 1.86, 95% CI 1.18-2.93, P=0.007). There is lack of evidence to suggest an association between MTHFR C677T and A1298C with the risk of NHL in the Malays and Chinese. In the Indians however, the MTHFR A1298C confers risk to NHL. This study suggests ethnicity modifies the relationship between polymorphisms in the folate-metabolizing gene and NHL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24646728     DOI: 10.1038/jhg.2014.19

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  39 in total

1.  Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.

Authors:  Olga A Gra; Andrey S Glotov; Eugene A Nikitin; Oleg S Glotov; Viktoria E Kuznetsova; Alexander V Chudinov; Andrey B Sudarikov; Tatyana V Nasedkina
Journal:  Am J Hematol       Date:  2008-04       Impact factor: 10.047

2.  Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes.

Authors:  Tracy J Lightfoot; Christine F Skibola; Eleanor V Willett; Danica R Skibola; James M Allan; Fabio Coppede; Peter J Adamson; Gareth J Morgan; Eve Roman; Martyn T Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-12       Impact factor: 4.254

3.  Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas.

Authors:  Sidonie Niclot; Quentin Pruvot; Caroline Besson; Daniel Savoy; Elisabeth Macintyre; Gilles Salles; Nicole Brousse; Bruno Varet; Paul Landais; Pierre Taupin; Claudine Junien; Dominique Baudry-Bluteau
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

4.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

Authors:  N M van der Put; F Gabreëls; E M Stevens; J A Smeitink; F J Trijbels; T K Eskes; L P van den Heuvel; H J Blom
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

5.  Normal frequencies of the C677T genotypes on the methylenetetrahydrofolate reductase (MTHFR) gene among lymphoproliferative disorders but not in multiple myeloma.

Authors:  A J González Ordóñez; J M Fernández Carreira; C R Fernández Alvarez; L Martin; J Sánchez Garcia; J M Medina Rodríguez; M V Alvarez; E Coto
Journal:  Leuk Lymphoma       Date:  2000-11

6.  Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma.

Authors:  Lisa F Lincz; Fiona E Scorgie; Ian Kerridge; Rachelle Potts; Andrew Spencer; Arno Enno
Journal:  Br J Haematol       Date:  2003-03       Impact factor: 6.998

7.  Methylenetetrahydrofolate reductase genotype association with the risk of follicular lymphoma.

Authors:  Said I Ismail; Nida A Ababneh; Yousef Khader; Ahmad A Abu-Khader; Abdullah Awidi
Journal:  Cancer Genet Cytogenet       Date:  2009-12

8.  MTHFR C677 T gene polymorphism in lymphoproliferative diseases.

Authors:  Ugur Deligezer; Ebru E Akisik; Fulya Yaman; Nilgün Erten; Nejat Dalay
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

9.  MTHFR 677 (C-->T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95.

Authors:  Kathrin Seidemann; Marion Book; Martin Zimmermann; Ulrike Meyer; Karl Welte; Martin Stanulla; Alfred Reiter
Journal:  Ann Hematol       Date:  2006-02-07       Impact factor: 3.673

10.  The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma.

Authors:  M Linnebank; S Schmidt; H Kölsch; A Linnebank; R Heun; I G H Schmidt-Wolf; A Glasmacher; K Fliessbach; T Klockgether; U Schlegel; H Pels
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

View more
  2 in total

1.  Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma.

Authors:  Sujatha Suthandiram; Gin-Gin Gan; Shamsul Mohd Zain; Ping-Chong Bee; Lay-Hoong Lian; Kian-Meng Chang; Tee-Chuan Ong; Zahurin Mohamed
Journal:  Tumour Biol       Date:  2014-11-11

2.  A direct isothermal amplification system adapted for rapid SNP genotyping of multifarious sample types.

Authors:  Xiaonan Liu; Chao Zhang; Mengye Zhao; Kewu Liu; Hang Li; Ningning Li; Linlin Gao; Xuemin Yang; Ting Ma; Juanli Zhu; Wenli Hui; Kai Hua; Yali Cui
Journal:  Biosens Bioelectron       Date:  2018-05-11       Impact factor: 10.618

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.